Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Danaher splashes $2bn on dental implant firm Nobel

This article was originally published in Clinica

Executive Summary

After several months of speculation, Danaher has agreed to buy number-two dental implant player Nobel Biocare for CHF17.10 ($18.27) per share. The all-cash deal is worth around $2.2bn, including assumed debt, and has been recommended by Nobel’s board of directors. The transaction is expected to close in late 2014 or early 2015.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT101918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel